Terms ending in 2033
Every in-force patent on MedImmune, LLC's record whose computed term ends in 2033, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US D821,572 | Drug Delivery Implement with Translucent Housing In force · High confidence | MedImmune, LLC | In force | High confidence | |
| US D822,199 | Drug Delivery Implement In force · High confidence | MedImmune, LLC | In force | High confidence | |
| US 10,253,345 | Cell Lines In force · Medium confidence | MedImmune Limited | In force | Medium confidence | |
| US 9,889,207 | Pyrrolobenzodiazepines and Conjugates Thereof In force · High confidence | MedImmune Limited | In force | High confidence | |
| US 10,335,497 | Pyrrolobenzodiazepines and Conjugates Thereof In force · High confidence | MedImmune Limited | In force | High confidence | |
| US 10,646,584 | Pyrrolobenzodiazepines and Conjugates Thereof In force · High confidence | MedImmune Limited | In force | High confidence | |
| US 10,736,903 | Pyrrolobenzodiazepine-Anti-Psma Antibody Conjugates In force · High confidence | MedImmune Limited | In force | High confidence | |
| US 10,780,181 | Pyrrolobenzodiazepine-Antibody Conjugates In force · High confidence | MedImmune Limited | In force | High confidence | |
| US 10,799,596 | Pyrrolobenzodiazepine-Antibody Conjugates In force · High confidence | MedImmune Limited | In force | High confidence | |
| US 10,994,023 | Pyrrolobenzodiazepines and Conjugates Thereof In force · High confidence | MedImmune Limited | In force | High confidence | |
| 18 more term ends in 2033 · Pro | |||||
10 of 28 patents shown. Soonest term end first, then patent number.
Pro members see all 28.
27 of these are in force and held by MedImmune, LLC.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.